SCHEMBL27409209

SCHEMBL27409209

BrCCc1ccc2ccncc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.51
TBXAS1 P24557 1/20 0.51
PRKCZ Q05513 1/20 0.43
MELK Q14680 2/20 0.42
MRGPRX4 Q96LA9 1/20 0.36
NAMPT P43490 1/20 0.36
CCNT1 O60563 1/20 0.36
PIM1 P11309 1/20 0.36
CDK9 P50750 1/20 0.36
HASPIN Q8TF76 1/20 0.36
IKBKB O14920 1/20 0.36
PRMT5 O14744 1/20 0.35
CYP51A1 Q16850 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
PRKCI P41743 1/20 0.35
TDO2 P48775 1/20 0.35
AKT1 P31749 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27503273 0.93 CYP19A1 (0.51) CYP19A1TBXAS1PRKCZMELKCCNT1
SCHEMBL30896286 0.85 CYP19A1 (0.54) CYP19A1TBXAS1PRKCZMELKMRGPRX4
SCHEMBL6042697 0.85 CYP19A1 (0.54) CYP19A1TBXAS1PRKCZMELKMRGPRX4
SCHEMBL6114835 0.81 CYP19A1 (0.51) CYP19A1TBXAS1PRKCZMELKCYP51A1
SCHEMBL6114785 0.79 CYP19A1 (0.49) CYP19A1TBXAS1PRKCZMELKHDAC3
SCHEMBL6114827 0.77 TDP1 (0.53) CYP19A1TBXAS1TDP1
SCHEMBL27938396 0.77 TDP1 (0.48) TDP1
SCHEMBL29612558 0.77 CYP19A1 (0.54) CYP19A1TBXAS1PRKCZMELKCCNT1
SCHEMBL6947317 0.77 CYP19A1 (0.54) CYP19A1TBXAS1PRKCZMELKCCNT1
SCHEMBL6897234 0.77 CYP19A1 (0.54) CYP19A1TBXAS1PRKCZMELKMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1256326-C Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 2006-05-17 CN disclosed
CN-1202152-A Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 1998-12-16 CN disclosed
CN-1077716-A ANTIVIRAL PEPTIDES PFIZER (US) 1993-10-27 CN disclosed